Patents by Inventor Thomas Conrads

Thomas Conrads has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9085604
    Abstract: A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: July 21, 2015
    Assignees: University of Maryland, Baltimore, The United States of America as represented by the Secretary of the Department of Health and Human Services, The United Sates of America as Represented by the Department of Veterans Affairs
    Inventors: Susan K. Keay, Zoltan Szekely, Thomas Conrads, Timothy Veenstra, Maria Michejda
  • Patent number: 8680056
    Abstract: A novel antiproliferative factor comprising a glycopeptide is disclosed. In specific embodiments, the novel antiproliferative factor is associated with the bladder. Compositions, diagnostic kits and reagents, and methods of using the compounds for identifying and/or treating interstitial cystitis and cancer are disclosed.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: March 25, 2014
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, University of Maryland, Baltimore, The United States of America as Represented by the Department of Veterans Affairs
    Inventors: Susan K. Keay, Zoltan Szekely, Thomas Conrads, Timothy Veenstra, Maria Michejda
  • Publication number: 20100055113
    Abstract: The present invention concerns the receptor for antiproliferative factor (APF) from bladder epithelial cells. In particular, there are compositions and methods for modulating APF, APF receptor, and/or the binding of APF to APF receptor. Agents that interfere with the binding of APF to its receptor or agents that enhance the binding of APF to its receptor are contemplated. In specific aspects, certain compositions are employed for a therapeutic purpose, such as interstitial cystitis or cancer, for example.
    Type: Application
    Filed: July 27, 2007
    Publication date: March 4, 2010
    Applicants: The University of Maryland, Baltimore, Government of the United States of America, as rep resented by the Secretary of the Dept. of Health
    Inventors: Susan K. Keay, Christopher Michejda, Gillian Tocci, Thomas Conrads, Timothy Veenstra, Brian Lewis Hood
  • Publication number: 20060057556
    Abstract: Contiguous capillaries useful for separating and electrospraying a fluid comprising analyte and electrolyte are provided. The contiguous capillaries have spray tips at one end of the capillaries and electrically conductive portions in proximity to the spray tips. Methods for making the contiguous capillaries and their use as electrospray sources are also disclosed. Apparatus and methods for conveying analyte ions from the capillaries into analytical instruments, such as a mass spectrometer, are also disclosed. The disclosed contiguous capillaries may be used to carryout electrophoresis separation and electrospray ionization of analytes. Methods for obtaining the mass spectra of macromolecular analytes at concentrations lower than previously possibly are provided using the apparatus and procedures described herein.
    Type: Application
    Filed: October 20, 2003
    Publication date: March 16, 2006
    Applicant: The Government of the United States of America Department of Health and Human Services
    Inventors: George Janini, Haleem Issaq, Timothy Veenstra, Thomas Conrads, Kenneth Wilkens